These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30810947)

  • 1. The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group.
    Beechinor RJ; Thompson PA; Hwang MF; Vargo RC; Bomgaars LR; Gerhart JG; Dreyer ZE; Gonzalez D
    Clin Pharmacokinet; 2019 Jul; 58(7):899-910. PubMed ID: 30810947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of methotrexate in Mexican pediatric patients with acute lymphoblastic leukemia.
    Medellin-Garibay SE; Hernández-Villa N; Correa-González LC; Morales-Barragán MN; Valero-Rivera KP; Reséndiz-Galván JE; Ortiz-Zamudio JJ; Milán-Segovia RDC; Romano-Moreno S
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):21-31. PubMed ID: 31673826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia.
    Aumente D; Buelga DS; Lukas JC; Gomez P; Torres A; García MJ
    Clin Pharmacokinet; 2006; 45(12):1227-38. PubMed ID: 17112298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Population pharmacokinetics of high-dose methotrexate administered in 329 children with acute lymphoblastic leukemia].
    Zhang CY; Gu J; Li YZ; Lu W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):106-10. PubMed ID: 18315911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation on individualized adjustment of target range of high-dose methotrexate].
    Hua Y; Zhao WH; Lu XT; Yang LH; Lu W
    Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetic Study and Individual Dose Adjustments of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia or Osteosarcoma.
    Hui KH; Chu HM; Fong PS; Cheng WTF; Lam TN
    J Clin Pharmacol; 2019 Apr; 59(4):566-577. PubMed ID: 30556906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population PK/PD model of homocysteine concentrations after high-dose methotrexate treatment in patients with acute lymphoblastic leukemia.
    Rühs H; Becker A; Drescher A; Panetta JC; Pui CH; Relling MV; Jaehde U
    PLoS One; 2012; 7(9):e46015. PubMed ID: 23049924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic study of delayed methotrexate excretion in children with acute lymphoblastic leukemia
.
    Zang YN; Wang SZ; Qin Y; Zhang JR; Zhao LB; Wang XL
    Int J Clin Pharmacol Ther; 2019 Aug; 57(8):402-407. PubMed ID: 31232278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
    Colom H; Farré R; Soy D; Peraire C; Cendros JM; Pardo N; Torrent M; Domenech J; Mangues MA
    Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities.
    Foster JH; Thompson PA; Bernhardt MB; Margolin JF; Hilsenbeck SG; Jo E; Marquez-Do DA; Scheurer ME; Schafer ES
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):349-360. PubMed ID: 30488179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic study of methotrexate in children with acute lymphoblastic leukemia.
    Zhang C; Zhai S; Yang L; Wu H; Zhang J; Ke X
    Int J Clin Pharmacol Ther; 2010 Jan; 48(1):11-21. PubMed ID: 20040335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study.
    Balis FM; Holcenberg JS; Poplack DG; Ge J; Sather HN; Murphy RF; Ames MM; Waskerwitz MJ; Tubergen DG; Zimm S; Gilchrist GS; Bleyer WA
    Blood; 1998 Nov; 92(10):3569-77. PubMed ID: 9808549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
    Chládková J; Hak J; Martínková J; Chládek J
    Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Body Fat on Population Pharmacokinetics of High-Dose Methotrexate in Pediatric Patients With Acute Lymphoblastic Leukemia.
    Orgel E; Nabais T; Douglas C; Mittelman SD; Neely M
    J Clin Pharmacol; 2021 Jun; 61(6):755-762. PubMed ID: 33314168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy.
    Faltaos DW; Hulot JS; Urien S; Morel V; Kaloshi G; Fernandez C; Xuan kH; Leblond V; Lechat P
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):626-33. PubMed ID: 16528531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia.
    Wall AM; Gajjar A; Link A; Mahmoud H; Pui CH; Relling MV
    Leukemia; 2000 Feb; 14(2):221-5. PubMed ID: 10673736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia.
    Thompson PA; Murry DJ; Rosner GL; Lunagomez S; Blaney SM; Berg SL; Camitta BM; Dreyer ZE; Bomgaars LR
    Cancer Chemother Pharmacol; 2007 May; 59(6):847-53. PubMed ID: 17136402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate.
    Ogungbenro K; Aarons L;
    J Pharmacokinet Pharmacodyn; 2014 Apr; 41(2):173-85. PubMed ID: 24651962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach.
    Odoul F; Le Guellec C; Lamagnère JP; Breilh D; Saux MC; Paintaud G; Autret-Leca E
    Fundam Clin Pharmacol; 1999; 13(5):595-604. PubMed ID: 10520733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of high-dose methotrexate in Chinese pediatric patients with medulloblastoma.
    Shi ZY; Liu YO; Gu HY; Xu XQ; Yan C; Yang XY; Yan D
    Biopharm Drug Dispos; 2020 Mar; 41(3):101-110. PubMed ID: 32017134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.